Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 12 Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date Authors Pearson S , Kietsiriroje N , Ajjan RA Received 4 September 2019 Accepted for publication 8 November 2019 Published 2 December 2019 Volume 2019:12 Pages 25152529 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Ming-Hui Zou Sam Pearson, 1, * Noppadol Kietsiriroje, 1, 2, * Ramzi A Ajjan 1 1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK
The researchers evaluated the impact of glycemic response-based targeted treatment on secondary outcomes like tolerability, weight change, long-term risks of adverse renal events, and incident microvascular and macrovascular problems
Now that modern medicine has made weight loss easier than ever, its hard not to backslide and internalize the message that we should all prioritize being smaller, despite the potential risks to our mental and physical health
Promotes metabolic efficiency , helping sustain healthy body composition and glucose metabolism
95% CI = 0.880.98, P = .005) compared to DPP-4 inhibitor use
Folate Deficiency Treatment To address folate deficiency anaemia , your GP will typically prescribe daily folic acid tablets to raise your folate levels
